Annual CFO:
-$43.81M+$6.76M(+13.37%)Summary
- As of today, JANX annual cash from operations is -$43.81 million, with the most recent change of +$6.76 million (+13.37%) on December 31, 2024.
- During the last 3 years, JANX annual cash from operations has fallen by -$26.84 million (-158.09%).
- JANX annual cash from operations is now -1044.57% below its all-time high of -$3.83 million, reached on December 31, 2019.
Performance
JANX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
-$12.86M+$10.96M(+46.01%)Summary
- As of today, JANX quarterly cash from operations is -$12.86 million, with the most recent change of +$10.96 million (+46.01%) on September 30, 2025.
- Over the past year, JANX quarterly cash from operations has dropped by -$10.63 million (-476.24%).
- JANX quarterly cash from operations is now -331.10% below its all-time high of $5.56 million, reached on March 31, 2021.
Performance
JANX Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$70.42M-$10.63M(-17.77%)Summary
- As of today, JANX TTM cash from operations is -$70.42 million, with the most recent change of -$10.63 million (-17.77%) on September 30, 2025.
- Over the past year, JANX TTM cash from operations has dropped by -$33.43 million (-90.37%).
- JANX TTM cash from operations is now -2003.70% below its all-time high of $3.70 million, reached on March 31, 2021.
Performance
JANX TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
JANX Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +13.4% | -476.2% | -90.4% |
| 3Y3 Years | -158.1% | +4.2% | -69.7% |
| 5Y5 Years | -1044.6% | -1087.1% | -2470.0% |
JANX Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -158.1% | +13.4% | -476.2% | +46.0% | -90.4% | at low |
| 5Y | 5-Year | -1044.6% | +13.4% | -331.1% | +46.0% | -2003.7% | at low |
| All-Time | All-Time | -1044.6% | +13.4% | -331.1% | +46.0% | -2003.7% | at low |
JANX Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$12.86M(+46.0%) | -$70.42M(-17.8%) |
| Jun 2025 | - | -$23.81M(-39.9%) | -$59.79M(-30.0%) |
| Mar 2025 | - | -$17.02M(-1.8%) | -$46.00M(-5.0%) |
| Dec 2024 | -$43.81M(+13.4%) | -$16.73M(-649.7%) | -$43.81M(-18.4%) |
| Sep 2024 | - | -$2.23M(+77.7%) | -$36.99M(+20.4%) |
| Jun 2024 | - | -$10.02M(+32.5%) | -$46.47M(+9.8%) |
| Mar 2024 | - | -$14.84M(-49.9%) | -$51.50M(-1.8%) |
| Dec 2023 | -$50.58M(-17.8%) | -$9.90M(+15.4%) | -$50.58M(+3.8%) |
| Sep 2023 | - | -$11.71M(+22.2%) | -$52.59M(+3.1%) |
| Jun 2023 | - | -$15.05M(-8.2%) | -$54.29M(-19.8%) |
| Mar 2023 | - | -$13.91M(-16.8%) | -$45.31M(-5.6%) |
| Dec 2022 | -$42.92M | -$11.91M(+11.2%) | -$42.92M(-3.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$13.41M(-120.9%) | -$41.49M(-22.3%) |
| Jun 2022 | - | -$6.07M(+47.3%) | -$33.93M(+0.4%) |
| Mar 2022 | - | -$11.52M(-9.9%) | -$34.06M(-100.6%) |
| Dec 2021 | -$16.98M(-288.6%) | -$10.48M(-79.0%) | -$16.98M(-161.4%) |
| Sep 2021 | - | -$5.85M(+5.6%) | -$6.50M(-276.7%) |
| Jun 2021 | - | -$6.20M(-211.5%) | -$1.72M(-146.6%) |
| Mar 2021 | - | $5.56M(+613.7%) | $3.70M(+235.0%) |
| Dec 2020 | -$4.37M(-14.1%) | - | - |
| Sep 2020 | - | -$1.08M(-38.7%) | -$2.74M(-65.4%) |
| Jun 2020 | - | -$781.00K(+10.8%) | -$1.66M(-89.2%) |
| Mar 2020 | - | -$876.00K | -$876.00K |
| Dec 2019 | -$3.83M | - | - |
FAQ
- What is Janux Therapeutics, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. annual cash from operations year-on-year change?
- What is Janux Therapeutics, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. quarterly cash from operations year-on-year change?
- What is Janux Therapeutics, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. TTM cash from operations year-on-year change?
What is Janux Therapeutics, Inc. annual cash from operations?
The current annual cash from operations of JANX is -$43.81M
What is the all-time high annual cash from operations for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high annual cash from operations is -$3.83M
What is Janux Therapeutics, Inc. annual cash from operations year-on-year change?
Over the past year, JANX annual cash from operations has changed by +$6.76M (+13.37%)
What is Janux Therapeutics, Inc. quarterly cash from operations?
The current quarterly cash from operations of JANX is -$12.86M
What is the all-time high quarterly cash from operations for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high quarterly cash from operations is $5.56M
What is Janux Therapeutics, Inc. quarterly cash from operations year-on-year change?
Over the past year, JANX quarterly cash from operations has changed by -$10.63M (-476.24%)
What is Janux Therapeutics, Inc. TTM cash from operations?
The current TTM cash from operations of JANX is -$70.42M
What is the all-time high TTM cash from operations for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high TTM cash from operations is $3.70M
What is Janux Therapeutics, Inc. TTM cash from operations year-on-year change?
Over the past year, JANX TTM cash from operations has changed by -$33.43M (-90.37%)